A new study analyzing gene expression among patients with glioblastomas has found that not all of the common, deadly brain tumors appear the same upon closer examination.
The research, directed by scientists at The University of Texas M. D. Anderson Cancer Center, identified three subgroups of tumors that differed according to the degree of overall methylation, [...]

Interleukin Genetics, Inc. (AMEX:ILI), and Geisinger Health System, have announced a research collaboration to explore the role of genetics in obesity. The goal of the collaboration is to develop a series of genetic tests that will help physicians better understand an individual’s inherited resistance to weight loss and, more specifically, gauge a patient’s likelihood of [...]

Recent reports have brought attention to the Food and Drug Administration’s (FDA’s) plan to list those drugs whose safety is under investigation because of complaints brought to the agency’s attention by drug companies, physicians, and patients.

A first-of-its-kind clinical trial may provide new treatment options to children with sickle cell disease (SCD), an inherited blood disorder that affects 70,000 people in the United States. The Sickle Cell Unrelated Transplant (SCURT) research study is a Phase II, multi-site clinical trial that will start accepting qualified patients later this month.

A new study of breast cancer radiation treatment performed at 21st Century Oncology has found that the SAVI™ applicator delivered excellent cosmetic results with minimal side effects, for women who had not qualified for breast conservation therapy using a previously available balloon device.